XML 47 R34.htm IDEA: XBRL DOCUMENT
v3.25.2

Consolidated Schedule of Investments (Unaudited) - Investments (Details) - USD ($) | Jun. 30, 2025 | Mar. 31, 2025 | Dec. 31, 2024 | Jun. 30, 2024 | Mar. 31, 2024 | Dec. 31, 2023
--- | --- | --- | --- | --- | --- | ---
Investments at cost | $ 745,848,000 |  | $ 766,774,000 |  |  |
Investments at fair value | 622,653,000 |  | 697,891,000 |  |  |
Unrestricted Short Term Investments [Member] |  |  |  |  |  |
Investments at cost | 53,261,000 |  | 27,266,000 |  |  |
Investments at fair value | 53,261,000 |  | 27,266,000 |  |  |
Restricted Short Term Investments [Member] |  |  |  |  |  |
Investments at cost | 3,226,000 |  | 3,338,000 |  |  |
Investments at fair value | 3,226,000 |  | 3,338,000 |  |  |
Equity Securities [Member] |  |  |  |  |  |
Investments at cost | 38,098,000 |  | 35,942,000 |  |  |
Investments at fair value | 13,402,000 |  | 26,198,000 |  |  |
Warrant [Member] |  |  |  |  |  |
Investments at cost | 15,565,000 |  | 15,956,000 |  |  |
Investments at fair value | 21,629,000 |  | 18,277,000 |  |  |
U S Bank Money Market Deposit Account [Member] | Unrestricted Short Term Investments [Member] |  |  |  |  |  |
Investments at cost | 53,261,000 |  | 27,266,000 |  |  |
Investments at fair value | 53,261,000 |  | 27,266,000 |  |  |
U S Bank Money Market Deposit Account [Member] | Restricted Short Term Investments [Member] |  |  |  |  |  |
Investments at cost | 3,226,000 |  | 3,338,000 |  |  |
Investments at fair value | 3,226,000 |  | 3,338,000 |  |  |
Other Sustainability Sector [Member] |  |  |  |  |  |
Investments at cost | 30,449,000 |  | 66,151,000 |  |  |
Investments at fair value | 23,008,000 |  | 66,079,000 |  |  |
Software Sector [Member] |  |  |  |  |  |
Investments at cost | 165,371,000 |  | 154,040,000 |  |  |
Investments at fair value | 158,536,000 |  | 151,043,000 |  |  |
Biotechnology Sector [Member] |  |  |  |  |  |
Investments at cost | 120,283,000 |  | 118,221,000 |  |  |
Investments at fair value | 84,043,000 |  | 97,562,000 |  |  |
Medical Device Sector [Member] |  |  |  |  |  |
Investments at cost | 239,170,000 |  | 213,564,000 |  |  |
Investments at fair value | 209,087,000 |  | 205,634,000 |  |  |
Energy Efficiency [Member] |  |  |  |  |  |
Investments at cost | 9,934,000 |  | 9,818,000 |  |  |
Investments at fair value | 9,828,000 |  | 9,712,000 |  |  |
Other Healthcare Sector [Member] |  |  |  |  |  |
Investments at cost | 39,575,000 |  | 39,533,000 |  |  |
Investments at fair value | 42,194,000 |  | 40,144,000 |  |  |
Networking Sector [Member] |  |  |  |  |  |
Investments at cost | 364,000 |  | 10,070,000 |  |  |
Investments at fair value | 121,000 |  | 9,827,000 |  |  |
Diagnostics Sector [Member] |  |  |  |  |  |
Investments at cost | 17,350,000 |  | 16,704,000 |  |  |
Investments at fair value | 9,940,000 |  | 13,701,000 |  |  |
Communications Sector [Member] |  |  |  |  |  |
Investments at cost | 517,000 |  | 11,711,000 |  |  |
Investments at fair value | 3,532,000 |  | 14,763,000 |  |  |
Investment, Affiliated Issuer, Controlled [Member] |  |  |  |  |  |
Investments at cost | 49,202,000 |  | 44,780,000 |  |  |
Investments at fair value | 10,455,000 | $ 14,869,000 | 31,819,000 | $ 11,386,000 | $ 13,644,000 | $ 14,223,000
Investment, Affiliated Issuer, Controlled [Member] | Debt Securities [Member] |  |  |  |  |  |
Investments at cost | 801,000 |  | 17,611,000 |  |  |
Investments at fair value | 801,000 |  | 7,668,000 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Equity Securities [Member] |  |  |  |  |  |
Investments at cost | 23,289,000 |  | 21,289,000 |  |  |
Investments at fair value | 7,910,000 |  | 17,921,000 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Other Investments [Member] |  |  |  |  |  |
Investments at cost | 25,112,000 |  | 5,880,000 |  |  |
Investments at fair value | 1,744,000 |  | 6,230,000 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Nexii Building Solutions, Inc [Member] |  |  |  |  |  |
Investments at fair value | 8,711,000 | 8,700,000 | 8,547,000 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] |  |  |  |  |  |
Investments at fair value | 879,000 | 879,000 | 0 | 5,550,000 | 7,799,000 | 7,993,000
Investment, Affiliated Issuer, Controlled [Member] | Swift Health Systems Inc. [Member] |  |  |  |  |  |
Investments at fair value | 0 | 0 | 17,042,000 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member] |  |  |  |  |  |
Investments at fair value | 865,000 | 5,290,000 | 6,230,000 | 5,836,000 | 5,845,000 | 6,230,000
Investment, Affiliated Issuer, Controlled [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Term Loan, Fixed Index One [Member] |  |  |  |  |  |
Principal Amount |  |  | 790,000 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Debt Securities [Member] |  |  |  |  |  |
Principal Amount | 790,000 |  |  |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Common Stock [Member] |  |  |  |  |  |
Investments at cost | 3,297,000 |  | 3,297,000 |  |  |
Investments at fair value | $ 0 |  | $ 0 |  |  |
Number of Shares (in shares) | 108,320 |  | 108,320 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Preferred Stock [Member] |  |  |  |  |  |
Investments at cost | $ 3,419,000 |  | $ 3,419,000 |  |  |
Investments at fair value | $ 7,910,000 |  | $ 7,909,000 |  |  |
Number of Shares (in shares) | 542 |  | 542 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount |  |  | $ 4,012,000 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount |  |  | 2,006,000 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount |  |  | 538,000 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |
Principal Amount |  |  | 532,000 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |
Principal Amount |  |  | 521,000 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |  |  |
Principal Amount |  |  | 513,000 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index, Seven [Member] |  |  |  |  |  |
Principal Amount |  |  | 505,000 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Common Stock [Member] |  |  |  |  |  |
Investments at cost | $ 639,000 |  | 639,000 |  |  |
Investments at fair value | $ 0 |  | $ 0 |  |  |
Number of Shares (in shares) | 2,278,272 |  | 2,278,272 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Preferred Stock [Member] |  |  |  |  |  |
Investments at cost | $ 3,922,000 |  | $ 3,922,000 |  |  |
Investments at fair value | $ 0 |  | $ 0 |  |  |
Number of Shares (in shares) | 5,350,142 |  | 5,350,142 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Other Investments [Member] |  |  |  |  |  |
Investments at cost | $ 10,703,000 |  |  |  |  |
Investments at fair value | 879,000 |  |  |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Biotechnology Sector [Member] | HIMV LLC [Member] | Other Investments [Member] |  |  |  |  |  |
Investments at cost | 5,880,000 |  | $ 5,880,000 |  |  |
Investments at fair value | 865,000 |  | 6,230,000 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount |  |  | 1,948,000 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount |  |  | 1,948,000 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount |  |  | 1,948,000 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |
Principal Amount |  |  | 1,948,000 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |
Principal Amount |  |  | 315,000 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |  |  |
Principal Amount |  |  | 156,000 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] | Preferred Stock [Member] |  |  |  |  |  |
Investments at cost | 12,012,000 |  | 10,012 |  |  |
Investments at fair value | $ 0 |  | $ 10,012 |  |  |
Number of Shares (in shares) | 4,233,666 |  | 3,588,505 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] | Other Investments [Member] |  |  |  |  |  |
Investments at cost | $ 8,529,000 |  |  |  |  |
Investments at fair value | 0 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] |  |  |  |  |  |
Investments at cost | 669,153,000 |  | $ 694,503,000 |  |  |
Investments at fair value | 605,491,000 |  | 657,765,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] |  |  |  |  |  |
Investments at cost | 635,460,000 |  | 660,556,000 |  |  |
Investments at fair value | 578,370,000 |  | 631,111,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Equity Securities [Member] |  |  |  |  |  |
Investments at cost | 9,809,000 |  | 9,653,000 |  |  |
Investments at fair value | 5,492,000 |  | 8,277,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |  |  |  |  |
Investments at cost | 15,438,000 |  | 15,829,000 |  |  |
Investments at fair value | 21,629,000 |  | 18,277,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Investments [Member] |  |  |  |  |  |
Investments at cost | 8,446,000 |  | 8,465,000 |  |  |
Investments at fair value | 0 |  | 100,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Common Stock [Member] |  |  |  |  |  |
Investments at cost | 250,000 |  | 250,000 |  |  |
Investments at fair value | $ 250,000 |  | $ 250,000 |  |  |
Number of Shares (in shares) | 1,162 |  | 1,162 |  |  |
Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Common Stock [Member] |  |  |  |  |  |
Investments at cost | $ 545,000 |  | $ 356,000 |  |  |
Investments at fair value | $ 655,000 |  | $ 356,000 |  |  |
Number of Shares (in shares) | 47,461 |  | 32,831 |  |  |
Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Preferred Stock [Member] |  |  |  |  |  |
Investments at cost | $ 89,000 |  | $ 89,000 |  |  |
Investments at fair value | $ 0 |  | $ 0 |  |  |
Number of Shares (in shares) | 2,688,971 |  | 2,688,971 |  |  |
Investment, Unaffiliated Issuer [Member] | Axiom Space, Inc [Member] | Preferred Stock [Member] |  |  |  |  |  |
Investments at cost | $ 261,000 |  | $ 261,000 |  |  |
Investments at fair value | $ 306,000 |  | $ 306,000 |  |  |
Number of Shares (in shares) | 1,810 |  | 1,810 |  |  |
Investment, Unaffiliated Issuer [Member] | Cognoa, Inc. [Member] | Common Stock [Member] |  |  |  |  |  |
Investments at cost | $ 487,000 |  | $ 487,000 |  |  |
Investments at fair value | $ 487,000 |  | $ 487,000 |  |  |
Number of Shares (in shares) | 8,123,877 |  | 8,123,877 |  |  |
Investment, Unaffiliated Issuer [Member] | Cognoa, Inc. [Member] | Preferred Stock [Member] |  |  |  |  |  |
Investments at cost | $ 250,000 |  | $ 250,000 |  |  |
Investments at fair value | $ 250,000 |  | $ 250,000 |  |  |
Number of Shares (in shares) | 1,059,636 |  | 1,059,636 |  |  |
Investment, Unaffiliated Issuer [Member] | Lumithera, Inc. [Member] | Common Stock [Member] |  |  |  |  |  |
Investments at cost | $ 2,000,000 |  | $ 2,000,000 |  |  |
Investments at fair value | $ 1,700,000 |  | $ 1,700,000 |  |  |
Number of Shares (in shares) | 392,651 |  | 392,651 |  |  |
Investment, Unaffiliated Issuer [Member] | Cadrenal Therapeutics, Inc. [Member] | Common Stock [Member] |  |  |  |  |  |
Investments at cost | $ 0 |  | $ 0 |  |  |
Investments at fair value | $ 482,000 |  | $ 580,000 |  |  |
Number of Shares (in shares) | 40,000 |  | 40,000 |  |  |
Investment, Unaffiliated Issuer [Member] | PebblePost, Inc [Member] | Preferred Stock [Member] |  |  |  |  |  |
Investments at cost | $ 73,000 |  | $ 73,000 |  |  |
Investments at fair value | $ 73,000 |  | $ 73,000 |  |  |
Number of Shares (in shares) | 56,212 |  | 56,212 |  |  |
Investment, Unaffiliated Issuer [Member] | Caastle, Inc [Member] | Preferred Stock [Member] |  |  |  |  |  |
Investments at cost | $ 2,681,000 |  | $ 2,681,000 |  |  |
Investments at fair value | $ 0 |  | $ 2,681,000 |  |  |
Number of Shares (in shares) | 242,180 |  | 242,180 |  |  |
Investment, Unaffiliated Issuer [Member] | Getaround, Inc [Member] | Common Stock [Member] |  |  |  |  |  |
Investments at cost | $ 253,000 |  | $ 253,000 |  |  |
Investments at fair value | $ 1,000 |  | $ 3,000 |  |  |
Number of Shares (in shares) | 87,082 |  | 87,082 |  |  |
Investment, Unaffiliated Issuer [Member] | SnagAJob.com, Inc [Member] | Common Stock [Member] |  |  |  |  |  |
Investments at cost | $ 9,000 |  | $ 9,000 |  |  |
Investments at fair value | $ 0 |  | $ 83,000 |  |  |
Number of Shares (in shares) | 82,974 |  | 82,974 |  |  |
Investment, Unaffiliated Issuer [Member] | Tigo Energy, Inc. [Member] | Common Stock [Member] |  |  |  |  |  |
Investments at cost | $ 111,000 |  | $ 111,000 |  |  |
Investments at fair value | $ 7,000 |  | $ 5,000 |  |  |
Number of Shares (in shares) | 5,205 |  | 5,205 |  |  |
Investment, Unaffiliated Issuer [Member] | Decisyon, Inc [Member] | Preferred Stock [Member] |  |  |  |  |  |
Investments at cost | $ 2,800,000 |  | $ 2,800,000 |  |  |
Investments at fair value | $ 1,281,000 |  | $ 1,281,000 |  |  |
Number of Shares (in shares) | 280,000 |  | 280,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Lotame Solutions, Inc. [Member] | Preferred Stock [Member] |  |  |  |  |  |
Investments at cost |  |  | $ 4,000 |  |  |
Investments at fair value |  |  | $ 193,000 |  |  |
Number of Shares (in shares) |  |  | 66,127 |  |  |
Investment, Unaffiliated Issuer [Member] | Lotame Solutions, Inc. [Member] | Preferred Stock 2 [Member] |  |  |  |  |  |
Investments at cost |  |  | $ 29,000 |  |  |
Investments at fair value |  |  | $ 29,000 |  |  |
Number of Shares (in shares) |  |  | 9,381 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount |  |  | $ 3,594,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount |  |  | 3,594,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | $ 5,000,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 2,500,000 |  | 2,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |
Principal Amount | 2,500,000 |  | 2,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |  |  |
Principal Amount | 2,500,000 |  | 2,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount |  |  | 3,750,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount |  |  | 3,750,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount |  |  | 7,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |
Principal Amount |  |  | 3,750,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |
Principal Amount |  |  | 3,750,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |  |  |
Principal Amount |  |  | 4,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Seven [Member] |  |  |  |  |  |
Principal Amount |  |  | 2,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Havenly, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | 1,556,000 |  | 2,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Havenly, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 2,333,000 |  | 3,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Havenly, Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount | 2,813,000 |  | 2,813,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Havenly, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |
Principal Amount | 2,813,000 |  | 2,813,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Lyrical Foods, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | 2,679,000 |  | 2,679,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | 6,313,000 |  | 6,042,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 3,157,000 |  | 3,021,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount | 2,525,000 |  | 2,417,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |
Principal Amount | 3,157,000 |  | 3,021,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |
Principal Amount | 3,788,000 |  | 3,625,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |  |  |
Principal Amount | 3,157,000 |  | 3,021,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Seven [Member] |  |  |  |  |  |
Principal Amount | 6,313,000 |  | 6,042,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Eight [Member] |  |  |  |  |  |
Principal Amount | 3,157,000 |  | 3,021,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Optoro, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | 2,500,000 |  | 2,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Optoro, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 1,875,000 |  | 1,875,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Standvast Holdings, LLC [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount |  |  | 2,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Standvast Holdings, LLC [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount |  |  | 2,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Standvast Holdings, LLC [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount |  |  | 2,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Unagi, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount |  |  | 1,415,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Unagi, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount |  |  | 708,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Unagi, Inc [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount |  |  | 708,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Crafty Holdings, Inc.[Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Crafty Holdings, Inc.[Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Kodiak Robotics, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | 8,333,000 |  | 10,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Kodiak Robotics, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 8,333,000 |  | 10,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Kodiak Robotics, Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount | 4,167,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Kodiak Robotics, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |
Principal Amount | 4,167,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Kodiak Robotics, Inc. [Member] | Term Loan, Fixed Index Two [Member] |  |  |  |  |  |
Principal Amount |  |  | 250,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Noodle Partners, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | 8,750,000 |  | 10,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Noodle Partners, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 4,375,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Noodle Partners, Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount | 4,375,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | BrightInsight, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | 7,000,000 |  | 7,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | BrightInsight, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 3,500,000 |  | 3,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | BrightInsight, Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount | 3,500,000 |  | 3,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | BrightInsight, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |
Principal Amount | 2,750,000 |  | 2,750,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | OneNetworks, Inc. dba Finexio [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount |  |  | 2,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | OneNetworks, Inc. dba Finexio [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount |  |  | 2,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Mirantis, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Mirantis, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Mirantis, Inc [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Mirantis, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | MasteryPrep, LLC [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | 7,500,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | MasteryPrep, LLC [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 7,500,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Elligo Health Research, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | 10,000,000 |  | 10,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Elligo Health Research, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Elligo Health Research, Inc [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Elligo Health Research, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Ursa Space Systems Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | 2,500,000 |  | 2,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Ursa Space Systems Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 2,500,000 |  | 2,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Viken Detection Corporation [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | 4,000,000 |  | 4,833,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Viken Detection Corporation [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 2,000,000 |  | 2,417,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Viken Detection Corporation [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount | 2,000,000 |  | 2,417,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | SafelyYou, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | SafelyYou, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | 2,500,000 |  | 2,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 3,500,000 |  | 3,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount | 2,500,000 |  | 2,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |
Principal Amount | 1,500,000 |  | 1,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Hound Labs, Inc. [Member] | Term Loan, Fixed Index One [Member] |  |  |  |  |  |
Principal Amount |  |  | 300,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 2,500,000 |  | 2,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount | 2,500,000 |  | 2,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |
Principal Amount | 2,500,000 |  | 2,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |
Principal Amount | 2,500,000 |  | 2,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |  |  |
Principal Amount | 2,500,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Crafty Holdings, Inc.[Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Crafty Holdings, Inc.[Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount |  |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Crafty Holdings, Inc.[Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount |  |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | DropOff, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | 6,804,000 |  | 6,804,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | DropOff, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 6,280,000 |  | 6,280,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | DropOff, Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount | 2,617,000 |  | 2,617,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | HappyCo, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | 3,000,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | HappyCo, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 3,000,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | HappyCo, Inc [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount | 2,000,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Avalo Therapeutics, Inc. [Member] | Common Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | 311,000 |  | 311,000 |  |  |
Investments at fair value | $ 0 |  | $ 0 |  |  |
Number of Shares (in shares) | 117 |  | 117 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount |  |  | $ 3,333,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount |  |  | 3,333,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount |  |  | 2,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |
Principal Amount |  |  | 3,333,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |
Principal Amount |  |  | 3,333,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |  |  |
Principal Amount |  |  | 2,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 279,000 |  | 214,000 |  |  |
Investments at fair value | $ 257,000 |  | $ 270,000 |  |  |
Number of Shares (in shares) | 9,775 |  | 7,404 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | $ 10,000,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 5,500,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Emalex Biosciences, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount |  |  | $ 4,167,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Emalex Biosciences, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount |  |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Emalex Biosciences, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | 176,000 |  | 176,000 |  |  |
Investments at fair value | $ 452,000 |  | $ 129,000 |  |  |
Number of Shares (in shares) | 110,402 |  | 110,402 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Emalex Biosciences, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | $ 1,667,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Emalex Biosciences, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 4,167,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Imunon, Inc [Member] | Common Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | 65,000 |  | $ 65,000 |  |  |
Investments at fair value | $ 0 |  | $ 0 |  |  |
Number of Shares (in shares) | 19,671 |  | 19,671 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | KSQ Therapeutics, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount |  |  | $ 6,250,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | KSQ Therapeutics, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount |  |  | 6,250,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | KSQ Therapeutics, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 118,000 |  | 50,000 |  |  |
Investments at fair value | $ 125,000 |  | $ 53,000 |  |  |
Number of Shares (in shares) | 105,768 |  | 48,076 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | KSQ Therapeutics, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | $ 4,750,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | KSQ Therapeutics, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 4,750,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | KSQ Therapeutics, Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount | 4,750,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | KSQ Therapeutics, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |
Principal Amount | 4,750,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | BioVaxys Technology Corp. [Member] | Common Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | 5,000 |  |  |  |  |
Investments at fair value | $ 3,000 |  |  |  |  |
Number of Shares (in shares) | 2,800,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Mustang Bio, Inc [Member] | Common Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 146,000 |  | $ 146,000 |  |  |
Investments at fair value | $ 0 |  | $ 0 |  |  |
Number of Shares (in shares) | 568 |  | 16,611 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Native Microbials, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount |  |  | $ 2,875,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Native Microbials, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount |  |  | 1,917,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Native Microbials, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 73,000 |  | 73,000 |  |  |
Investments at fair value | $ 64,000 |  | $ 68,000 |  |  |
Number of Shares (in shares) | 112,879 |  | 112,879 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Native Microbials, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | $ 2,125,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Native Microbials, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 1,417,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | PDS Biotechnology Corporation [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount |  |  | $ 8,750,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | PDS Biotechnology Corporation [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount |  |  | 3,281,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | PDS Biotechnology Corporation [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount |  |  | 3,281,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | PDS Biotechnology Corporation [Member] | Common Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | 160,000 |  | 160,000 |  |  |
Investments at fair value | $ 4,000 |  | $ 14,000 |  |  |
Number of Shares (in shares) | 299,848 |  | 299,848 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount |  |  | $ 3,482,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount |  |  | 3,482,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount |  |  | 1,741,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |
Principal Amount |  |  | 1,741,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |
Principal Amount |  |  | 1,741,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |  |  |
Principal Amount |  |  | 1,741,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Common Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 278,000 |  | 278,000 |  |  |
Investments at fair value | $ 0 |  | $ 0 |  |  |
Number of Shares (in shares) | 175,098 |  | 175,098 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 312,000 |  | $ 312,000 |  |  |
Investments at fair value | $ 0 |  | $ 59,000 |  |  |
Number of Shares (in shares) | 709,980 |  | 709,980 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | $ 3,482,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 3,482,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount | 1,741,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |
Principal Amount | 1,741,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |
Principal Amount | 1,741,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |  |  |
Principal Amount | 1,741,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Greenlight Biosciences, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount |  |  | $ 1,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Greenlight Biosciences, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount |  |  | 500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Greenlight Biosciences, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | 167,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Greenlight Biosciences, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 83,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Stealth BioTherapeutics Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount |  |  | 2,024,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Stealth BioTherapeutics Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount |  |  | 1,012,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Stealth BioTherapeutics Inc. [Member] | Common Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | 264,000 |  | 264,000 |  |  |
Investments at fair value | $ 5,000 |  | $ 0 |  |  |
Number of Shares (in shares) | 318,181 |  | 318,181 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Stealth BioTherapeutics Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | $ 810,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Stealth BioTherapeutics Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 405,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Tallac Therapeutics, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount |  |  | $ 2,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Tallac Therapeutics, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount |  |  | 2,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Tallac Therapeutics, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | 198,000 |  | 194,000 |  |  |
Investments at fair value | $ 0 |  | $ 167,000 |  |  |
Number of Shares (in shares) | 2,266,669 |  | 1,600,002 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Tallac Therapeutics, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | $ 2,500,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Tallac Therapeutics, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 2,500,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Xeris Pharmaceuticals, Inc [Member] | Common Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | 73,000 |  | $ 73,000 |  |  |
Investments at fair value | $ 229,000 |  | $ 91,000 |  |  |
Number of Shares (in shares) | 126,000 |  | 126,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Long Grove Pharmaceuticals, LLC [Member] | Term Loan, SOFR Index, One [Member] |  |  |  |  |  |
Principal Amount | $ 10,138,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Debt Securities [Member] |  |  |  |  |  |
Investments at cost | 288,355,000 |  | $ 263,280,000 |  |  |
Investments at fair value | 275,746,000 |  | 261,520,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Warrant [Member] |  |  |  |  |  |
Investments at cost | 5,206,000 |  | 5,149,000 |  |  |
Investments at fair value | 5,988,000 |  | 6,374,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Magnolia Medical Technologies, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | 194,000 |  | 194,000 |  |  |
Investments at fair value | $ 549,000 |  | $ 368,000 |  |  |
Number of Shares (in shares) | 900,043 |  | 809,931 |  |  |
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | VERO Biotech LLC [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 377,000 |  | $ 376,000 |  |  |
Investments at fair value | $ 191,000 |  | $ 198,000 |  |  |
Number of Shares (in shares) | 3,701 |  | 3,701 |  |  |
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Meditrina, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 83,000 |  | $ 83,000 |  |  |
Investments at fair value | $ 31,000 |  | $ 34,000 |  |  |
Number of Shares (in shares) | 233,993 |  | 233,993 |  |  |
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | MicroTransponder, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 47,000 |  | $ 47,000 |  |  |
Investments at fair value | $ 50,000 |  | $ 66,000 |  |  |
Number of Shares (in shares) | 103,172 |  | 103,172 |  |  |
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Onkos Surgical, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 192,000 |  | $ 192,000 |  |  |
Investments at fair value | $ 221,000 |  | $ 187,000 |  |  |
Number of Shares (in shares) | 443,674 |  | 443,674 |  |  |
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Scientia Vascular, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 163,000 |  | $ 103,000 |  |  |
Investments at fair value | $ 487,000 |  | $ 262,000 |  |  |
Number of Shares (in shares) | 58,410 |  | 34,410 |  |  |
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Sonex Health, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 275,000 |  | $ 275,000 |  |  |
Investments at fair value | $ 258,000 |  | $ 266,000 |  |  |
Number of Shares (in shares) | 2,637,133 |  | 2,637,133 |  |  |
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Spineology, Inc [Member] | Common Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 143,000 |  | $ 143,000 |  |  |
Investments at fair value | $ 107,000 |  | $ 108,000 |  |  |
Number of Shares (in shares) | 27,139 |  | 2,714,033 |  |  |
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Spineology, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 17,000 |  | $ 16,000 |  |  |
Investments at fair value | $ 28,000 |  | $ 28,000 |  |  |
Number of Shares (in shares) | 22,551 |  | 2,255,155 |  |  |
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Lumithera, Inc. [Member] | Royalty Agreement [Member] |  |  |  |  |  |
Investments at cost | $ 1,116,000 |  | $ 1,146,000 |  |  |
Investments at fair value | 0 |  | 100,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Robin Healthcare, Inc. [Member] | Royalty Agreement [Member] |  |  |  |  |  |
Investments at cost | 7,330,000 |  | 7,319,000 |  |  |
Investments at fair value | 0 |  | 0 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] |  |  |  |  |  |
Investments at cost |  |  | 8,918,000 |  |  |
Investments at fair value |  |  | 10,650,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Debt Securities [Member] |  |  |  |  |  |
Investments at cost | 202,437,000 |  | 222,699,000 |  |  |
Investments at fair value | 173,265,000 |  | 198,350,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Warrant [Member] |  |  |  |  |  |
Investments at cost | 8,483,000 |  |  |  |  |
Investments at fair value | 12,385,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Havenly, Inc. [Member] | Common Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | 3,178,000 |  | 3,178,000 |  |  |
Investments at fair value | $ 3,107,000 |  | $ 3,106,000 |  |  |
Number of Shares (in shares) | 1,446,429 |  | 1,446,429 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Kodiak Robotics, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 273,000 |  | $ 273,000 |  |  |
Investments at fair value | $ 2,551,000 |  | $ 15,000 |  |  |
Number of Shares (in shares) | 639,918 |  | 639,918 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Noodle Partners, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 116,000 |  | $ 116,000 |  |  |
Investments at fair value | $ 0 |  | $ 0 |  |  |
Number of Shares (in shares) | 84,037 |  | 84,037 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | OneNetworks, Inc. dba Finexio [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 3,000 |  | $ 3,000 |  |  |
Investments at fair value | $ 3,000 |  | $ 3,000 |  |  |
Number of Shares (in shares) | 184,646 |  | 184,646 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Revinate Holdings, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 44,000 |  | $ 44,000 |  |  |
Investments at fair value | $ 87,000 |  | $ 90,000 |  |  |
Number of Shares (in shares) | 682,034 |  | 682,034 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | SIGNiX, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 177,000 |  | $ 225,000 |  |  |
Investments at fair value | $ 0 |  | $ 0 |  |  |
Number of Shares (in shares) | 186,235 |  | 186,235 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Mirantis, Inc [Member] | Common Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 223,000 |  | $ 223,000 |  |  |
Investments at fair value | $ 425,000 |  | $ 585,000 |  |  |
Number of Shares (in shares) | 948,275 |  | 948,275 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Slingshot Aerospace, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 123,000 |  | $ 123,000 |  |  |
Investments at fair value | $ 30,000 |  | $ 66,000 |  |  |
Number of Shares (in shares) | 309,208 |  | 309,208 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | NextCar Holding Company, Inc [Member] | Common Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 188,000 |  | $ 188,000 |  |  |
Investments at fair value | $ 0 |  | $ 0 |  |  |
Number of Shares (in shares) | 12,618 |  | 12,618 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | NextCar Holding Company, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 9,000 |  | $ 9,000 |  |  |
Investments at fair value | $ 0 |  | $ 0 |  |  |
Number of Shares (in shares) | 3,913,723 |  | 3,913,723 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Supply Network Visiblity Holdings LLC [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 64,000 |  | $ 65,000 |  |  |
Investments at fair value | $ 73,000 |  | $ 75,000 |  |  |
Number of Shares (in shares) | 682 |  | 682 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Topia Mobility, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 138,000 |  | $ 138,000 |  |  |
Investments at fair value | $ 0 |  | $ 0 |  |  |
Number of Shares (in shares) | 30,496 |  | 30,496 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Ursa Space Systems Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 151,000 |  | $ 151,000 |  |  |
Investments at fair value | $ 144,000 |  | $ 148,000 |  |  |
Number of Shares (in shares) | 1,075,072 |  | 1,075,072 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Viken Detection Corporation [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 120,000 |  | $ 120,000 |  |  |
Investments at fair value | $ 374,000 |  | $ 234,000 |  |  |
Number of Shares (in shares) | 345,443 |  | 345,443 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | xAd, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 177,000 |  | $ 177,000 |  |  |
Investments at fair value | $ 6,000 |  | $ 6,000 |  |  |
Number of Shares (in shares) | 4,343,348 |  | 4,343,348 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Optoro, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 182,000 |  | $ 182,000 |  |  |
Investments at fair value | $ 0 |  | $ 99,000 |  |  |
Number of Shares (in shares) | 11,550 |  | 11,550 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Standvast Holdings, LLC [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost |  |  | $ 275,000 |  |  |
Investments at fair value |  |  | $ 0 |  |  |
Number of Shares (in shares) |  |  | 1,225,492 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Britecore Holdings, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 98,000 |  | $ 98,000 |  |  |
Investments at fair value | $ 237,000 |  | $ 289,000 |  |  |
Number of Shares (in shares) | 161,215 |  | 161,215 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Axiom Space, Inc [Member] | Common Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 45,000 |  | $ 46,000 |  |  |
Investments at fair value | $ 24,000 |  | $ 35,000 |  |  |
Number of Shares (in shares) | 1,991 |  | 1,991 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Unagi, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost |  |  | $ 32,000 |  |  |
Investments at fair value |  |  | $ 0 |  |  |
Number of Shares (in shares) |  |  | 171,081 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Intelepeer Holdings, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 138,000 |  | $ 138,000 |  |  |
Investments at fair value | $ 3,129,000 |  | $ 3,156,000 |  |  |
Number of Shares (in shares) | 2,936,535 |  | 2,936,535 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Alula Holdings, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 93,000 |  | $ 93,000 |  |  |
Investments at fair value | $ 7,000 |  | $ 7,000 |  |  |
Number of Shares (in shares) | 20,000 |  | 20,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | CAMP NYC, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 36,000 |  | $ 36,000 |  |  |
Investments at fair value | $ 39,000 |  | $ 40,000 |  |  |
Number of Shares (in shares) | 112,356 |  | 112,356 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Fictiv, Inc. [Member] | Common Stock Warrants [Member] |  |  |  |  |  |
Investments at cost |  |  | $ 59,000 |  |  |
Investments at fair value |  |  | $ 77,000 |  |  |
Number of Shares (in shares) |  |  | 126,841 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Clara Foods Co [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 30,000 |  | $ 30,000 |  |  |
Investments at fair value | $ 42,000 |  | $ 43,000 |  |  |
Number of Shares (in shares) | 46,745 |  | 46,745 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Divergent Technologies, Inc. [Member] | Common Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 79,000 |  | $ 79,000 |  |  |
Investments at fair value | $ 4,000 |  | $ 7,000 |  |  |
Number of Shares (in shares) | 9,801 |  | 9,801 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Divergent Technologies, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 454,000 |  | $ 454,000 |  |  |
Investments at fair value | $ 442,000 |  | $ 440,000 |  |  |
Number of Shares (in shares) | 45,273 |  | 45,273 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Crafty Holdings, Inc.[Member] | Common Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 132,000 |  | $ 132,000 |  |  |
Investments at fair value | $ 132,000 |  | $ 132,000 |  |  |
Number of Shares (in shares) | 243,278 |  | 243,278 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | MyForest Foods Co [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 29,000 |  | $ 29,000 |  |  |
Investments at fair value | $ 24,000 |  | $ 25,000 |  |  |
Number of Shares (in shares) | 250 |  | 250 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | DropOff, Inc. [Member] | Common Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 455,000 |  | $ 455,000 |  |  |
Investments at fair value | $ 0 |  | $ 0 |  |  |
Number of Shares (in shares) | 516,535 |  | 516,535 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | HappyCo, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 26,000 |  |  |  |  |
Investments at fair value | $ 23,000 |  |  |  |  |
Number of Shares (in shares) | 96,228 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Primary Kids, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 57,000 |  | $ 57,000 |  |  |
Investments at fair value | $ 333,000 |  | $ 412,000 |  |  |
Number of Shares (in shares) | 553,778 |  | 553,778 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Quip NYC Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 325,000 |  | $ 325,000 |  |  |
Investments at fair value | $ 0 |  | $ 0 |  |  |
Number of Shares (in shares) | 6,191 |  | 6,191 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Updater, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 34,000 |  | $ 34,000 |  |  |
Investments at fair value | $ 26,000 |  | $ 26,000 |  |  |
Number of Shares (in shares) | 108,333 |  | 108,333 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | CPG Beyond, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 242,000 |  | $ 242,000 |  |  |
Investments at fair value | $ 226,000 |  | $ 231,000 |  |  |
Number of Shares (in shares) | 500,000 |  | 500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Silk, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 175,000 |  | $ 175,000 |  |  |
Investments at fair value | $ 104,000 |  | $ 119,000 |  |  |
Number of Shares (in shares) | 394,110 |  | 394,110 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Global Worldwide LLC [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 75,000 |  | $ 75,000 |  |  |
Investments at fair value | $ 0 |  | $ 0 |  |  |
Number of Shares (in shares) | 245,810 |  | 245,810 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Rocket Lawyer Incorporated [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 92,000 |  | $ 92,000 |  |  |
Investments at fair value | $ 216,000 |  | $ 319,000 |  |  |
Number of Shares (in shares) | 261,721 |  | 261,721 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Skillshare, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 162,000 |  | $ 162,000 |  |  |
Investments at fair value | $ 389,000 |  | $ 680,000 |  |  |
Number of Shares (in shares) | 139,074 |  | 139,074 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Liqid, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 364,000 |  | $ 364,000 |  |  |
Investments at fair value | $ 121,000 |  | $ 103,000 |  |  |
Number of Shares (in shares) | 344,102 |  | 344,102 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Avalanche Technology, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost |  |  | $ 45,000 |  |  |
Investments at fair value |  |  | $ 0 |  |  |
Number of Shares (in shares) |  |  | 5,938 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | E La Carte, Inc [Member] | Common Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 60,000 |  | $ 60,000 |  |  |
Investments at fair value | $ 0 |  | $ 0 |  |  |
Number of Shares (in shares) | 147,361 |  | 147,361 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Everstream Holdings, LLC [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 82,000 |  | $ 82,000 |  |  |
Investments at fair value | $ 24,000 |  | $ 34,000 |  |  |
Number of Shares (in shares) | 525,000 |  | 525,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Lemongrass Holdings, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 34,000 |  | $ 34,000 |  |  |
Investments at fair value | $ 43,000 |  | $ 48,000 |  |  |
Number of Shares (in shares) | 101,308 |  | 101,308 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Ceribell, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | $ 5,000,000 |  | $ 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Ceribell, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Ceribell, Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount | 4,000,000 |  | 4,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Ceribell, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | 147,000 |  | 147,000 |  |  |
Investments at fair value | $ 927,000 |  | $ 1,573,000 |  |  |
Number of Shares (in shares) | 89,903 |  | 89,903 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | VERO Biotech LLC [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | $ 15,000,000 |  | $ 15,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | VERO Biotech LLC [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 10,000,000 |  | 10,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | VERO Biotech LLC [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | VERO Biotech LLC [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |
Principal Amount | 2,500,000 |  | 2,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Candesant Biomedical, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount |  |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Candesant Biomedical, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount |  |  | 2,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Candesant Biomedical, Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount |  |  | 2,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Candesant Biomedical, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost |  |  | 152,000 |  |  |
Investments at fair value |  |  | $ 78,000 |  |  |
Number of Shares (in shares) |  |  | 93,336 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | MicroTransponder, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | 3,750,000 |  | $ 3,750,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | MicroTransponder, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 3,750,000 |  | 3,750,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Onkos Surgical, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | 10,000,000 |  | 10,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Onkos Surgical, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 10,000,000 |  | 10,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Onkos Surgical, Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Onkos Surgical, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Conventus Orthopaedics, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | 2,801,000 |  | 3,187,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Conventus Orthopaedics, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 2,801,000 |  | 3,187,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Conventus Orthopaedics, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | 268,000 |  | 256,000 |  |  |
Investments at fair value | $ 1,000 |  | $ 102,000 |  |  |
Number of Shares (in shares) | 13,203,395 |  | 9,313,541 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Scientia Vascular, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | $ 10,000,000 |  | $ 3,750,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Scientia Vascular, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 10,000,000 |  | 3,750,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Scientia Vascular, Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Scientia Vascular, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |
Principal Amount | 1,500,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | 2,500,000 |  | 2,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 2,500,000 |  | 2,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |
Principal Amount | 3,750,000 |  | 3,750,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |  |  |
Principal Amount | 3,750,000 |  | 3,750,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Seven [Member] |  |  |  |  |  |
Principal Amount | 3,750,000 |  | 3,750,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Eight [Member] |  |  |  |  |  |
Principal Amount | 3,750,000 |  | 3,750,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | InfoBionic, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | InfoBionic, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | InfoBionic, Inc [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | InfoBionic, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | 231,000 |  | 231,000 |  |  |
Investments at fair value | $ 169,000 |  | $ 175,000 |  |  |
Number of Shares (in shares) | 5,361,130 |  | 5,361,130 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Pivot Bio, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | $ 5,000,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Spineology, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  | $ 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Spineology, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 4,250,000 |  | 4,250,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Spineology, Inc [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount | 4,250,000 |  | 4,250,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Spineology, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |
Principal Amount | 2,500,000 |  | 2,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | MML US, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | 2,526,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | MML US, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 2,526,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | MML US, Inc [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount | 5,051,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | MML US, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |
Principal Amount | 5,051,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | MML US, Inc [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |
Principal Amount | 5,013,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | MML US, Inc [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |  |  |
Principal Amount | 5,013,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | AccuVein Inc [Member] | Common Stock Warrants [Member] |  |  |  |  |  |
Investments at cost |  |  | 7,000 |  |  |
Investments at fair value |  |  | $ 0 |  |  |
Number of Shares (in shares) |  |  | 271 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerin Medical, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | 65,000 |  | $ 65,000 |  |  |
Investments at fair value | $ 1,349,000 |  | $ 1,418,000 |  |  |
Number of Shares (in shares) | 1,818,183 |  | 1,818,183 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member] | Term Loan, Fixed Index One [Member] |  |  |  |  |  |
Principal Amount |  |  | $ 2,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member] | Term Loan, Fixed Index Two [Member] |  |  |  |  |  |
Principal Amount |  |  | 2,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member] | Term Loan, Fixed Index Three [Member] |  |  |  |  |  |
Principal Amount |  |  | 200,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 48,000 |  | 48,000 |  |  |
Investments at fair value | $ 0 |  | $ 16,000 |  |  |
Number of Shares (in shares) | 8,800 |  | 8,800 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | $ 2,500,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 2,500,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount | 200,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Canary Medical Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | 86,000 |  | $ 86,000 |  |  |
Investments at fair value | $ 1,000 |  | $ 2,000 |  |  |
Number of Shares (in shares) | 12,153 |  | 12,153 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Cognoa, Inc. [Member] | Common Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 0 |  | $ 0 |  |  |
Investments at fair value | $ 2,000 |  | $ 2,000 |  |  |
Number of Shares (in shares) | 30,585 |  | 30,585 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Cognoa, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 162,000 |  | $ 162,000 |  |  |
Investments at fair value | $ 1,000 |  | $ 1,000 |  |  |
Number of Shares (in shares) | 4,635,991 |  | 4,635,991 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | CSA Medical, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 174,000 |  | $ 174,000 |  |  |
Investments at fair value | $ 468,000 |  | $ 479,000 |  |  |
Number of Shares (in shares) | 4,939,813 |  | 4,917,794 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | CVRx, Inc [Member] | Common Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 76,000 |  | $ 76,000 |  |  |
Investments at fair value | $ 9,000 |  | $ 160,000 |  |  |
Number of Shares (in shares) | 47,410 |  | 47,410 |  |  |
Investment, Unaffiliated Issuer [Member] | Energy Efficiency [Member] | Pivot Bio, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | $ 5,000,000 |  | $ 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Energy Efficiency [Member] | Pivot Bio, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount |  |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Alternative Energy Sector [Member] | Sparkcharge, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | 2,500,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Alternative Energy Sector [Member] | Sparkcharge, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 2,500,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Alternative Energy Sector [Member] | Sparkcharge, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | 45,000 |  |  |  |  |
Investments at fair value | $ 36,000 |  |  |  |  |
Number of Shares (in shares) | 2,264,151 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member] | Debt Securities [Member] |  |  |  |  |  |
Investments at cost | $ 36,850,000 |  | 67,637,000 |  |  |
Investments at fair value | 28,843,000 |  | 67,052,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member] | Warrant [Member] |  |  |  |  |  |
Investments at cost | 759,000 |  | 715,000 |  |  |
Investments at fair value | 120,000 |  | 187,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member] | Pivot Bio, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | 14,000 |  | 14,000 |  |  |
Investments at fair value | $ 12,000 |  | $ 14,000 |  |  |
Number of Shares (in shares) | 210,418 |  | 210,418 |  |  |
Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 81,000 |  | $ 82,000 |  |  |
Investments at fair value | $ 12,000 |  | $ 17,000 |  |  |
Number of Shares (in shares) | 400,000 |  | 400,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member] | Soli Organic, Inc [Member] | Common Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 20,000 |  | $ 20,000 |  |  |
Investments at fair value | $ 0 |  | $ 19,000 |  |  |
Number of Shares (in shares) | 296 |  | 296 |  |  |
Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member] | Soli Organic, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 382,000 |  | $ 382,000 |  |  |
Investments at fair value | $ 0 |  | $ 10,000 |  |  |
Number of Shares (in shares) | 1,075 |  | 1,075 |  |  |
Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member] | LiquiGlide, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 39,000 |  | $ 39,000 |  |  |
Investments at fair value | $ 23,000 |  | $ 25,000 |  |  |
Number of Shares (in shares) | 61,359 |  | 61,359 |  |  |
Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member] | Temperpack Technologies, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 178,000 |  | $ 178,000 |  |  |
Investments at fair value | $ 37,000 |  | $ 102,000 |  |  |
Number of Shares (in shares) | 49,693 |  | 49,693 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Healthcare Sector [Member] | GT Medical Technologies, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | $ 3,750,000 |  | $ 3,750,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Healthcare Sector [Member] | GT Medical Technologies, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 3,750,000 |  | 3,750,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Healthcare Sector [Member] | GT Medical Technologies, Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount | 7,500,000 |  | 7,500,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Healthcare Sector [Member] | Hometeam Technologies, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Healthcare Sector [Member] | Hometeam Technologies, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Healthcare Sector [Member] | Hometeam Technologies, Inc [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Healthcare Sector [Member] | Hometeam Technologies, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Healthcare Sector [Member] | Hometeam Technologies, Inc [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | Debt Securities [Member] |  |  |  |  |  |
Investments at cost | 107,818,000 |  | 106,940,000 |  |  |
Investments at fair value | 100,516,000 |  | 104,189,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | Warrant [Member] |  |  |  |  |  |
Investments at cost | 990,000 |  | 1,047,000 |  |  |
Investments at fair value | 3,136,000 |  | 1,066,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | BrightInsight, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | 167,000 |  | 167,000 |  |  |
Investments at fair value | $ 0 |  | $ 0 |  |  |
Number of Shares (in shares) | 85,066 |  | 85,066 |  |  |
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | SafelyYou, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 164,000 |  | $ 163,000 |  |  |
Investments at fair value | $ 144,000 |  | $ 149,000 |  |  |
Number of Shares (in shares) | 206,983 |  | 150,353 |  |  |
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | GT Medical Technologies, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 83,000 |  | $ 83,000 |  |  |
Investments at fair value | $ 92,000 |  | $ 95,000 |  |  |
Number of Shares (in shares) | 195,984 |  | 195,984 |  |  |
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | Hound Labs, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 46,000 |  | $ 45,000 |  |  |
Investments at fair value | $ 0 |  | $ 0 |  |  |
Number of Shares (in shares) | 451,796 |  | 451,796 |  |  |
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | Parse Biosciences, Inc. [Member] | Common Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 71,000 |  | $ 71,000 |  |  |
Investments at fair value | $ 43,000 |  | $ 15,000 |  |  |
Number of Shares (in shares) | 32,244 |  | 32,244 |  |  |
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | Parse Biosciences, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 166,000 |  | $ 166,000 |  |  |
Investments at fair value | $ 132,000 |  | $ 15,000 |  |  |
Number of Shares (in shares) | 184,253 |  | 184,253 |  |  |
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | Kate Farms, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 102,000 |  | $ 101,000 |  |  |
Investments at fair value | $ 2,712,000 |  | $ 700,000 |  |  |
Number of Shares (in shares) | 82,965 |  | 82,965 |  |  |
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | Elligo Healthcare Research, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost | $ 191,000 |  | $ 191,000 |  |  |
Investments at fair value | $ 13,000 |  | $ 92,000 |  |  |
Number of Shares (in shares) | 652,250 |  | 652,250 |  |  |
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | Medsphere Systems Corporation [Member] | Preferred Stock Warrants [Member] |  |  |  |  |  |
Investments at cost |  |  | $ 60,000 |  |  |
Investments at fair value |  |  | $ 0 |  |  |
Number of Shares (in shares) |  |  | 7,097,792 |  |  |
Investment, Unaffiliated Issuer [Member] | Networking Sector [Member] | Fictiv, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount |  |  | $ 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Networking Sector [Member] | Fictiv, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount |  |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | $ 1,929,000 |  | 1,607,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 1,607,000 |  | 1,607,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount | 1,607,000 |  | 3,214,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |  |  |
Principal Amount | 964,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |  |  |
Principal Amount | 3,214,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] | Term Loan, Fixed Index One [Member] |  |  |  |  |  |
Principal Amount | 300,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] | Term Loan, Fixed Index Two [Member] |  |  |  |  |  |
Principal Amount | 250,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Parse Biosciences, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Parse Biosciences, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount | 5,000,000 |  |  |  |  |
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Parse Biosciences, Inc. [Member] | Term Loan, Fixed Index Two [Member] |  |  |  |  |  |
Principal Amount |  |  | 5,000,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Communications Sector [Member] | Axiom Space, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |  |  |
Principal Amount |  |  | 3,750,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Communications Sector [Member] | Axiom Space, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |  |  |
Principal Amount |  |  | 3,750,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Communications Sector [Member] | Axiom Space, Inc [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |  |  |
Principal Amount |  |  | 3,750,000 |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] |  |  |  |  |  |
Investments at cost | 27,493,000 |  | 27,491,000 |  |  |
Investments at fair value | 6,707,000 | 8,307,000 | 8,307,000 | 15,847,000 | 12,577,000 | 1,132,000
Investment, Affiliated Issuer, Noncontrolled [Member] | Equity Securities [Member] |  |  |  |  |  |
Investments at cost | 5,000,000 |  | 5,000,000 |  |  |
Investments at fair value | 0 |  | 0 |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Warrant [Member] |  |  |  |  |  |
Investments at cost | 127,000 |  | 127,000 |  |  |
Investments at fair value | 0 |  | 0 |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Other Investments [Member] |  |  |  |  |  |
Investments at cost | 22,366,000 |  | 22,364,000 |  |  |
Investments at fair value | 6,707,000 |  | 8,307,000 |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] |  |  |  |  |  |
Investments at fair value | 6,707,000 | 8,307,000 | 8,307,000 | 15,847,000 | 12,577,000 | 1,132,000
Investment, Affiliated Issuer, Noncontrolled [Member] | Aulea Medical, Inc. [Member] |  |  |  |  |  |
Investments at fair value | 0 | $ 0 | 0 | $ 0 | $ 0 | $ 0
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Other Investments, Prime Index, One [Member] |  |  |  |  |  |
Investments at cost | 22,366,000 |  | 4,910,000 |  |  |
Investments at fair value | 6,707,000 |  | 1,825,000 |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Common Stock [Member] |  |  |  |  |  |
Investments at cost | 5,000,000 |  | 5,000,000 |  |  |
Investments at fair value | $ 0 |  | $ 0 |  |  |
Number of Shares (in shares) | 2,164,502 |  | 2,164,502 |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Other Investments, Prime Index, Two [Member] |  |  |  |  |  |
Investments at cost |  |  | $ 7,634,000 |  |  |
Investments at fair value |  |  | 2,832,000 |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Other Investments, Prime Index, Three [Member] |  |  |  |  |  |
Investments at cost |  |  | 2,946,000 |  |  |
Investments at fair value |  |  | 1,095,000 |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Other Investments, Prime Index, Four [Member] |  |  |  |  |  |
Investments at cost |  |  | 2,946,000 |  |  |
Investments at fair value |  |  | 1,095,000 |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Warrant [Member] |  |  |  |  |  |
Investments at cost | $ 127,000 |  | 127,000 |  |  |
Investments at fair value | $ 0 |  | $ 0 |  |  |
Number of Shares (in shares) | 23,196 |  | 23,196 |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Other Investments, Prime Index, Five [Member] |  |  |  |  |  |
Investments at cost |  |  | $ 1,964,000 |  |  |
Investments at fair value |  |  | 730,000 |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Other Investments, Prime Index, Six [Member] |  |  |  |  |  |
Investments at cost |  |  | 1,964,000 |  |  |
Investments at fair value |  |  | 730,000 |  |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Medical Device Sector [Member] | Aulea Medical, Inc. [Member] | Common Stock [Member] |  |  |  |  |  |
Investments at cost | $ 0 |  | 0 |  |  |
Investments at fair value | $ 0 |  | $ 0 |  |  |
Number of Shares (in shares) | 660,537 |  | 660,537 |  |  |

X
- Definition Cost of the investment. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(d)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 19 -Subparagraph (3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-19 + Details
Name: | us-gaap_InvestmentOwnedAtCost
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value of investment in security owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(11)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-2 Reference 11: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12 Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(d)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(2)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(2)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 6)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 6)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 7)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 9)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 7)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedAtFairValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of principal of investment owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedBalancePrincipalAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Number of shares of investment owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedBalanceShares
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_UnrestrictedShortTermInvestmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_RestrictedShortTermInvestmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_USBankMoneyMarketDepositAccountMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_OtherSustainabilitySectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SoftwareSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_BiotechnologySectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_MedicalDeviceSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_EnergyEfficiencyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_OtherHealthcareSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_NetworkingSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_DiagnosticsSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_CommunicationsSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerControlledMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_OtherInvestmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NexiiBuildingSolutionsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_BetterPlaceForestsCoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SwiftHealthSystemsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HIMVLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanFixedIndexOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_PreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_ConsumerrelatedTechnologiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexFiveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexSixMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexSevenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentUnaffiliatedIssuerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CastleCreekBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_EmalexBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NextcarHoldingCompanyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AxiomSpaceIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CognoaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LumitheraIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CadrenalTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_PebblepostIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CaastleIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GetaroundIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SnagajobcomIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TigoEnergyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_DecisyonIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LotameSolutionsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_PreferredStock2Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NewAerofarmsIncAssigneeOfAerofarmsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SoliOrganicIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TemperpackTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HavenlyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LyricalFoodsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexEightMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_OptoroIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_StandvastHoldingsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_UnagiIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CraftyHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_KodiakRoboticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanFixedIndexTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NoodlePartnersIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_BrightinsightIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_OneNetworksIncdbaFinexioMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MirantisIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MasteryprepLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ElligoHealthResearchIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_UrsaSpaceSystemsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_VikenDetectionCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SafelyYouIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SupplyNetworkVisibilityHoldingsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HoundLabsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_BritecoreHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_DropOffIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HappyCoIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AvaloTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_CommonStockWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_PreferredStockWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ImunonIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_KSQTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_BiovaxysTechnologyCorpMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MustangBioIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NativeMicrobialsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_PDSBiotechnologyCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ProviviIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexFiveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexSixMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GreenlightBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_StealthBioTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TallacTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_XerisPharmaceuticalsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LongGrovePharmaceuticalLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanSofrIndexOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_LifeScienceSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MagnoliaMedicalTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_VeroBiotechLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MeditrinaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MicroTransponderIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_OnkosSurgicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ScientiaVascularIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SonexHealthIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SpineologyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_RoyaltyAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RobinHealthcareIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_TechnologySectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RevinateHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SignixIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SlingshotAerospaceIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SupplyNetworkVisiblityHoldingsLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TopiaMobilityIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_XadIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_IntelepeerHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AlulaHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CampNYCIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_FictivIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ClaraFoodsCoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_DivergentTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MyforestFoodsCoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_PrimaryKidsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_QuipNycIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_UpdaterIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CPGBeyondIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SilkIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GlobalWorldwideLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RocketLawyerIncorporatedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SkillshareIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LiqidIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AvalancheTechnologyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ELaCarteIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_EverstreamHoldingsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LemongrassHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CeribellIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CandesantBiomedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ConventusOrthopaedicsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_InfobionicIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_PivotBioIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MMLUSIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AccuveinIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AerinMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AerobiotixLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanFixedIndexThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CanaryMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CSAMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CVRXIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_AlternativeEnergySectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SparkchargeIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SustainabilitySegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LiquiglideIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GTMedicalTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HometeamTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_HealthcareInformationAndServicesSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ParseBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_KateFarmsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ElligoHealthcareResearchIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MedsphereSystemsCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_EveloBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AuleaMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_OtherInvestmentsPrimeIndexOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_OtherInvestmentsPrimeIndexTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_OtherInvestmentsPrimeIndexThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_OtherInvestmentsPrimeIndexFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_OtherInvestmentsPrimeIndexFiveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_OtherInvestmentsPrimeIndexSixMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |